Asymmetrex Obtains UK Patent for Tissue Stem Cell-Specific Counting and Testing

Oct 08, 2019

PTC Therapeutics Establishes Strategic Collaboration with Aldevron to Support GMP Plasmid Manufacturing

Oct 07, 2019

Posted by PTC Therapeutics, Inc.

PTC Therapeutics Announces New Real-World Analysis Demonstrating Translarna™ (ataluren) Slows Disease Progression in Patients with Duchenne Muscular Dystrophy

Oct 04, 2019

Posted by PTC Therapeutics, Inc.

Akero Therapeutics and InSphero partner to evaluate AKR-001 using InSphero’s 3D InSight™ Human Liver Disease platform

Oct 03, 2019

Asymmetrex Leads OCTNE 2019 Discussion of the Growing Need for Tissue Stem Cell-Specific Dosing In Stem Cell Clinical Trials

Oct 03, 2019

Elicio Therapeutics Completes $33 Million Series B Financing

Oct 02, 2019

Posted by Elicio Therapeutics

BioIVT Appoints Global Business Strategist Lori Ball as Its Chief Operating Officer

Oct 02, 2019

Posted by BioIVT

Risdiplam Spinal Muscular Atrophy Data Demonstrating Continued Benefit Presented at World Muscle Society Congress

Oct 02, 2019

Posted by PTC Therapeutics, Inc.

GMP Quality Assurance Consultants

Sep 30, 2019

PTC Therapeutics to Participate at Upcoming Investor Conferences

Sep 29, 2019

Posted by PTC Therapeutics, Inc.

Kephera Diagnostics awarded contract from the National Cancer Institute for development of a test for parasite linked to a rare cancer

Sep 26, 2019

Posted by Kephera Diagnostics

Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash

Sep 25, 2019